3β-trans-CLD alleviates metabolic dysfunction-associated steatotic liver disease (MASLD) via modulating the IDO1/Nrf2/SREBP1/SCD1 axis in vitro
The publisher did not provide an abstract — full text is available via the link below.
The publisher did not provide an abstract — full text is available via the link below.